{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:05:48Z","timestamp":1789085148466,"version":"build-2803163510"},"reference-count":78,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12DA061526"],"award-info":[{"award-number":["K12DA061526"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R13DA058520"],"award-info":[{"award-number":["R13DA058520"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000875","name":"Pew Charitable Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000875","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Addiction Journal"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>Methadone treatment (MT) for opioid use disorder saves lives, but the US MT system has long been dominated by punitive policies and practices that make MT inaccessible, burdensome, and traumatic for patients. After generations without changes to methadone regulations, a confluence of circumstance\u2014including the COVID-19 pandemic and an overdose crisis that has taken over a million lives\u2014has begun to shift the MT advocacy and political landscape. This commentary describes the building of the \u201cLiberate Methadone\u201d movement; a grassroots effort led by people with lived and living experience with methadone, addiction clinicians, researchers, community leaders, and people with many of these identities. The Liberate Methadone movement is dedicated to building a more accessible, equitable MT system that prioritizes patient health, promotes dignity, and is grounded in evidence. We describe the experience of planning and hosting a national conference and generating proceedings with recommendations for needed incremental and structural reforms within the US MT system. The lessons learned from this movement can motivate others across clinical, research, and policy roles to partner with and learn from patient and community-led groups, guiding needed reforms within systems of care. It is through these joint efforts and listening to those directly impacted groups who have been left out of the conversation for far too long, that we can successfully reduce overdose and suffering, toward better health, dignity, and thriving in our communities.<\/jats:p>","DOI":"10.1177\/29767342251377189","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:35:16Z","timestamp":1761496516000},"page":"316-325","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Envisioning a Humane and Accessible US Methadone Treatment System: Generating Policy and Practice Recommendations From the Liberate Methadone Movement"],"prefix":"10.1177","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7396-3938","authenticated-orcid":false,"given":"Noa","family":"Krawczyk","sequence":"first","affiliation":[{"name":"Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Scott","sequence":"additional","affiliation":[{"name":"Pennsylvania Harm Reduction Network, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Miller","sequence":"additional","affiliation":[{"name":"Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Coulter","sequence":"additional","affiliation":[{"name":"Medication Assisted Treatment Support and Awareness, Morgantown, WV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Ferguson","sequence":"additional","affiliation":[{"name":"National Survivors Union, Greensboro, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Frank","sequence":"additional","affiliation":[{"name":"Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayana","family":"Jordan","sequence":"additional","affiliation":[{"name":"Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA"},{"name":"Department of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Joudrey","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeon D.","family":"Kimmel","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine and Infectious Diseases, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-7492","authenticated-orcid":false,"given":"Ximena A.","family":"Levander","sequence":"additional","affiliation":[{"name":"Section of Addiction Medicine, Division of General Internal Medicine and Geriatrics, Department of Medicine, Oregon Health &amp; Science University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Potee","sequence":"additional","affiliation":[{"name":"Behavioral Health Network, Springfield, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate E.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Bryn Mawr College, Graduate School of Social Work and Social Research, Bryn Mawr, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Russell","sequence":"additional","affiliation":[{"name":"The Kirby Institute, University of South Wales (UNSW), Kensington, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA"},{"name":"Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly L.","family":"Sue","sequence":"additional","affiliation":[{"name":"Program in Addiction Medicine, Division of General Internal Medicine, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie W.","family":"Suen","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Vincent","sequence":"additional","affiliation":[{"name":"National Survivors Union, Greensboro, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Voyles","sequence":"additional","affiliation":[{"name":"Indiana Recovery Alliance, Bloomington, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5677-297X","authenticated-orcid":false,"given":"Caty","family":"Simon","sequence":"additional","affiliation":[{"name":"Whose Corner is it Anyway, Holyoke, MA, USA"},{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,10,26]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.17226\/25310"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000075"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab289"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103786"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.0976"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"e_1_3_3_8_2","unstructured":"Bromley L Kahan M Regenstreif L Srivastava A Wyman J. Methadone Treatment for People Who Use Fentanyl: Recommendations. META:PHI; 2021. www.metaphi.ca."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.07.019"},{"key":"e_1_3_3_10_2","unstructured":"Substance Abuse and Mental Health Services Administration. National Survey of Substance Abuse Treatment Services (N-SSATS): 2020 Data On Substance Abuse Treatment Facilities. SAMHSA. 2021. Accessed April 10 2024. https:\/\/www.samhsa.gov\/data\/report\/national-survey-substance-abuse-treatment-services-n-ssats-2020-data-substance-abuse"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.12333"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.17226\/4899"},{"key":"e_1_3_3_13_2","unstructured":"Opioid treatment programs: a key treatment system component. pew charitable trusts. July 16 2021. Accessed June 12 2024. https:\/\/pew.org\/3AVbDPo"},{"key":"e_1_3_3_14_2","unstructured":"Dooling B Stanley L. Extending Pandemic Flexibilities for Opioid Use Disorder Treatment: Unsupervised Use of Opioid Treatment Medications. The Georgy Washington University. Accessed March 15 2025. https:\/\/regulatorystudies.columbian.gwu.edu\/sites\/g\/files\/zaxdzs4751\/files\/downloads\/PEW_Opioids\/GW%20Reg%20Studies_REPORT_Take-Home%20Supplies_BDooling%20and%20LStanley.pdf"},{"key":"e_1_3_3_15_2","unstructured":"Duff JH Carter JA. Location of Medication-Assisted Treatment for Opioid Addiction: In Brief. Congressional Research Service; 2019. https:\/\/sgp.fas.org\/crs\/misc\/R45782.pdf"},{"key":"e_1_3_3_16_2","unstructured":"NIDA. Fewer than half of U.S. jails provide life-saving medications for opioid use disorder. National Institute on Drug Abuse. September 24 2024. Accessed March 24 2025. https:\/\/nida.nih.gov\/news-events\/news-releases\/2024\/09\/fewer-than-half-of-us-jails-provide-life-saving-medications-for-opioid-use-disorder"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.1624"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.12562"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103127"},{"key":"e_1_3_3_20_2","volume-title":"Federal Guidelines for Opioid Treatment Programs","author":"Substance Abuse and Mental Health Services Administration","year":"2015","unstructured":"Substance Abuse and Mental Health Services Administration. Federal Guidelines for Opioid Treatment Programs. Substance Abuse and Mental Health Services Administration; 2015."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00535-y"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/1049732311432718"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/nin.12275"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1525\/9780520943315"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2021.306665"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/10550490903077820"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1017\/S089803061600035X"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1108\/S1057-6290(2012)0000014008"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1057\/biosoc.2015.46"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/PHH.0000000000001168"},{"key":"e_1_3_3_31_2","unstructured":"Roberts S. The politics of stigma and racialization in the early years of methadone maintenance regulation. Published online 2022. Accessed March 15 2025. https:\/\/www.nationalacademies.org\/documents\/embed\/link\/LF2255DA3DD1C41C0A42D3BEF0989ACAECE3053A6A9B\/file\/D4F35602BCE0AD3C6FCAD4515932EF817FD6D4CB9791?noSaveAs=1"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.31620"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.36612"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3711"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa2212412"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.3673"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2021.107113"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2021.21040381"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.15620\/cdc\/170565"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2024.4011"},{"key":"e_1_3_3_41_2","unstructured":"Thomas K Silver-Greenberg J. Fraud and Fakery at the country\u2019s largest chain of methadone clinics. The New York Times. December 7 2024. Accessed March 24 2025. https:\/\/www.nytimes.com\/2024\/12\/07\/health\/acadia-methadone-clinics-fraud.html"},{"key":"e_1_3_3_42_2","unstructured":"Milloy J. The work of getting clean. CONTINGENT. January 14 2020. Accessed July 14 2025. https:\/\/contingentmagazine.org\/2020\/01\/13\/the-work-of-getting-clean\/"},{"key":"e_1_3_3_43_2","unstructured":"Rights panel hears of job bias on ex-addicts. The New York Times. January 9 1973. Accessed July 14 2025. https:\/\/www.nytimes.com\/1973\/01\/09\/archives\/rights-panel-hears-of-job-bias-on-exaddicts-4year-study-cited-case.html."},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104487"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.15087"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-018-4801-3"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.05.018"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.15641"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107968"},{"key":"e_1_3_3_50_2","unstructured":"Federal Register Volume 64 Issue 140 (Thursday July 22 1999). Accessed July 16 2025. https:\/\/www.govinfo.gov\/content\/pkg\/FR-1999-07-22\/html\/99-18562.htm"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108246"},{"key":"e_1_3_3_52_2","unstructured":"Harris SJ Meyer A Whaley S et al In their own words\u2014experiences of people who use drugs during the COVID-19 pandemic_2022.Pdf. 2022. Accessed September 23 2024. https:\/\/americanhealth.jhu.edu\/sites\/default\/files\/2022-03\/In%20Their%20Own%20Words%20-%20Experiences%20of%20People%20Who%20Use%20Drugs%20During%20the%20COVID-19%20Pandemic_2022.pdf"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108074"},{"key":"e_1_3_3_54_2","article-title":"To save lives from opioid overdose deaths, bring methadone into mainstream medicine","author":"Adams Z","unstructured":"Adams Z, Krawczyk N, Simon R, Suen L, Joudrey P. To save lives from opioid overdose deaths, bring methadone into mainstream medicine. Health Affairs Forefront. Published online May 27, 2022. doi:10.1377\/forefront.20220524.911965","journal-title":"Health Affairs Forefront"},{"key":"e_1_3_3_55_2","unstructured":"SAMHSA. Methadone take-home flexibilities extension guidance. Accessed March 14 2025. https:\/\/www.samhsa.gov\/substance-use\/treatment\/opioid-treatment-program\/methadone-guidance"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(23)00023-3"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.1776"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108449"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108276"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2021.1979991"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108288"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274094"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.focus.2023.100177"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxad018"},{"key":"e_1_3_3_65_2","unstructured":"Filter Staff. Vast coalition issues demands for far-reaching MAT reform. Filter. April 16 2020. Accessed March 24 2025. https:\/\/filtermag.org\/buprenorphine-methadone-reform-coronavirus\/"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/adaw.32685"},{"key":"e_1_3_3_67_2","unstructured":"Vincent L Tilley J Levenson B Vakharia S. Nation\u2019s leading drug policy experts demand medication assisted treatment and COVID-19: treatment reforms. Published online April 13 2020. Accessed March 24 2025. https:\/\/www.iowaharmreductioncoalition.org\/wp-content\/uploads\/2020\/06\/MAT-and-COVID-19-Treatment-Recommendations-4.14.20-release-.pdf"},{"key":"e_1_3_3_68_2","unstructured":"THE METHADONE MANIFESTO. Accessed March 24 2025. https:\/\/sway.cloud.microsoft\/UjvQx4ZNnXAYxhe7"},{"key":"e_1_3_3_69_2","unstructured":"Who We Are. Accessed November 4 2024. https:\/\/www.liberatemethadone.org\/who-we-are"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.17226\/26635"},{"key":"e_1_3_3_71_2","unstructured":"Substance Abuse and Mental Health Services Administration. Harm reduction framework. 2023. Accessed June 12 2025. https:\/\/www.samhsa.gov\/sites\/default\/files\/harm-reduction-framework.pdf"},{"key":"e_1_3_3_72_2","unstructured":"NIDA. To address the fentanyl crisis greater access to methadone is needed. National Institute on Drug Abuse. July 29 2024. Accessed November 4 2024. https:\/\/nida.nih.gov\/about-nida\/noras-blog\/2024\/07\/to-address-the-fentanyl-crisis-greater-access-to-methadone-is-needed"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1975344"},{"key":"e_1_3_3_74_2","unstructured":"Office of National Drug Control Policy. Published online 2021. Accessed April 12 2025. https:\/\/www.whitehouse.gov\/wp-content\/uploads\/2021\/03\/BidenHarris-Statement-of-Drug-Policy-Priorities-April-1.pdf"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-025-00535-4"},{"key":"e_1_3_3_76_2","unstructured":"National Coalition to Liberate Methadone National Survivors Union NYU Langone Center for Opioid Epidemiology and Policy (COEP). Liberating methadone: a roadmap for change conference proceedings and recommendations. 2024. Accessed November 4 2024. https:\/\/drive.google.com\/file\/u\/1\/d\/1eRwpgfpfuR9Miphk5b7BsHRs4TEeYOBC\/view?usp=embed_facebook"},{"key":"e_1_3_3_77_2","unstructured":"42 CFR Part 8\u2014medications for the treatment of opioid use disorder. Accessed November 25 2024. https:\/\/www.ecfr.gov\/current\/title-42\/chapter-I\/subchapter-A\/part-8?toc=1"},{"key":"e_1_3_3_78_2","unstructured":"Senators Markey and Paul introduce bipartisan legislation to modernize improve methadone treatment amid skyrocketing opioid overdoses and deaths. Accessed June 12 2024. https:\/\/www.markey.senate.gov\/news\/press-releases\/senators-markey-and-paul-introduce-bipartisan-legislation-to-modernize-improve-methadone-treatment-amid-skyrocketing-opioid-overdoses-and-deaths"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.19914"}],"container-title":["Substance Use &amp; Addiction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342251377189","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/29767342251377189","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342251377189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:52:06Z","timestamp":1777600326000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/29767342251377189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,26]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1177\/29767342251377189"],"URL":"https:\/\/doi.org\/10.1177\/29767342251377189","relation":{},"ISSN":["2976-7342","2976-7350"],"issn-type":[{"value":"2976-7342","type":"print"},{"value":"2976-7350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,26]]}}}